{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:43:20Z","timestamp":1788281000365,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Vaccine Evaluation Consortium","award":["039\/0031"],"award-info":[{"award-number":["039\/0031"]}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research Health Protection Research Unit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002141","name":"Public Health England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.vaccine.2020.02.024","type":"journal-article","created":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T08:17:40Z","timestamp":1581754660000},"page":"2660-2670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2\u201316\u00a0years after successive annual vaccinations with LAIV"],"prefix":"10.1016","volume":"38","author":[{"given":"Katja","family":"Hoschler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Maharjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Southern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blessing","family":"Okai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Baldevarona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick J.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.02.024_b0005","unstructured":"Hakin B, Cosford P, Harvey F. The flu immunisation programme 2013\/14 \u2013 extension to children. Available at: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/225360\/Children_s_flu_letter_2013.pdf."},{"key":"10.1016\/j.vaccine.2020.02.024_b0010","unstructured":"Annual National Flu Programme Letter 2019-2020. NHS England. Available at: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2019\/03\/annual-national-flu-programme-2019-to-2020-1.pdf."},{"key":"10.1016\/j.vaccine.2020.02.024_b0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/cid\/cit692","article-title":"Administration of AS03B-adjuvanted A(H1N1)pdm09 vaccine in children aged <3 years enhances antibody response to H3 and B viruses following a single dose of trivalent vaccine one year later","volume":"58","author":"Hoschler","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.02.024_b0020","unstructured":"Public Health England. The Green Book: Immunisation against infectious disease. Available at: https:\/\/www.gov.uk\/government\/collections\/immunisation-against-infectious-disease-the-green-book."},{"key":"10.1016\/j.vaccine.2020.02.024_b0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0033-3506(01)00444-9","article-title":"A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children","volume":"115","author":"Vyse","year":"2001","journal-title":"Public Health"},{"key":"10.1016\/j.vaccine.2020.02.024_b0030","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1016\/j.vaccine.2018.04.017","article-title":"Responses to live attenuated influenza vaccine in children vaccinated previously with Pandemrix (ASO3B adjuvanted pandemic A\/H1N1pdm09)","volume":"36","author":"Hoschler","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.024_b0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0035-9203(95)90680-0","article-title":"Salivary antibody detection in epidemiological surveys: a pilot study after a mass vaccination campaign against rubella in Sao Paulo, Brazil","volume":"89","author":"de Azevedo Neto","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2020.02.024_b0040","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1016\/j.vaccine.2008.07.013","article-title":"Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5\u201349 years of age","volume":"26","author":"Block","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.024_b0045","article-title":"Viral shedding in recipients of live attenuated influenza vaccine in the 2016\/17 and 2017\/18 influenza seasons in the United Kingdom","author":"Jackson","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.02.024_b0050","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1016\/j.vaccine.2012.09.018","article-title":"The role of nasal IgA in children vaccinated with live attenuated influenza vaccine","volume":"30","author":"Ambrose","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.024_b0055","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00414-16","article-title":"Comparisons of the humoral and cellular immune responses induced by live attenuated influenza vaccine and inactivated influenza vaccine in adults","volume":"24","author":"Hoft","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.02.024_b0060","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/21645515.2017.1377376","article-title":"Immune responses after live attenuated influenza vaccination","volume":"14","author":"Mohn","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.02.024_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(19)30086-4","article-title":"Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 study","author":"Lindsey","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2020.02.024_b0070","article-title":"Immunogenicity and viral shedding of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled trial among pre-school aged children in urban Bangladesh","author":"Lewis","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.02.024_b0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/archdischild-2016-312165","article-title":"Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere","volume":"103","author":"Pebody","year":"2018","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2020.02.024_b0080","article-title":"Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014\/15 end of season results","volume":"20","author":"Pebody","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2020.02.024_b0085","article-title":"Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015\/16 end-of-season results","volume":"21","author":"Pebody","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2020.02.024_b0090","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.44.17-00306","article-title":"End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016\/17","volume":"22","author":"Pebody","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2020.02.024_b0095","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.vaccine.2018.01.016","article-title":"Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013\u20132014 season","volume":"36","author":"King","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.02.024_b0100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1423-0410.2012.01599.x","article-title":"Strategies for screening blood donors to source convalescent H1N1v plasma for intervention therapy","volume":"103","author":"Parry","year":"2012","journal-title":"Vox Sang"},{"key":"10.1016\/j.vaccine.2020.02.024_b0105","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays","volume":"37","author":"Rowe","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.02.024_b0110","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/irv.12591","article-title":"Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses","volume":"12","author":"Trombetta","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2020.02.024_b0115","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1128\/jcm.13.3.554-560.1981","article-title":"Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses","volume":"13","author":"Murphy","year":"1981","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.02.024_b0120","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jcv.2008.06.012","article-title":"A commercial ELISA detects high levels of human H5 antibody but cross-reacts with influenza A antibodies","volume":"43","author":"Stelzer-Braid","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2020.02.024_b0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1473-3099(01)00169-4","article-title":"Novel methods for the detection of microbial antibodies in oral fluid","volume":"2","author":"McKie","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.02.024_b0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.coviro.2016.12.004","article-title":"Immune history and influenza virus susceptibility","volume":"22","author":"Cobey","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2020.02.024_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185666","article-title":"Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains","volume":"12","author":"Nunez","year":"2017","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20302218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20302218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:39:52Z","timestamp":1759401592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20302218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0264410X20302218"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2\u201316\u00a0years after successive annual vaccinations with LAIV","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}